Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma Meeting Abstract


Authors: Perry, J. R.; Cloughesy, T.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; Sulman, E. P.; Weller, M.; Wen, P. Y.; Hyddmark, E.; Mikkelson, T.; Owen, S. P.; Mason, W. P.; Drappatz, J.; Blondin, N. A.; de Groot, J. F.
Abstract Title: Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
Meeting Title: 19th Meeting of the European Association of Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 5
Meeting Dates: 2024 Oct 17-20
Meeting Location: Glasgow, United Kingdom
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-10-01
Start Page: v5
Language: English
ACCESSION: WOS:001340502000012
DOI: 10.1093/neuonc/noae144.013
PROVIDER: wos
Notes: Meeting Abstract: KS03.5.A -- Abstract Citation ID: NOAE144.013 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors